ArticleClinicoEconomics and outcomes research : CEOR2021

A Cost Effectiveness Analysis of Rivaroxaban Compared to Warfarin for Deep Vein Thrombosis (DVT) Treatment in Ethiopia.

Manaye Tamrie Derseh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.